INSIGHTS+ EMA Marketing Authorization of New Drugs in November 2024ByDipanshu DixitDecember 19, 20240Comments
News Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara) ByDipanshu DixitDecember 19, 20240Comments
News Ionis’ Tryngolza (Olezarsen) Receives the US FDA’s Approval to Treat Adults with Familial Chylomicronemia Syndrome (FCS) ByDipanshu DixitDecember 19, 20240Comments
VIEWPOINTS Lilly at UEGW 2024: Mark Genovese in an Illuminating Dialogue Exchange with PharmaShots shares insights into VIVID-1 studyBySaurabh ChaubeyDecember 18, 20240Comments
News Xcovery Holdings Receives US FDA Approval for Ensacove (Ensartinib) to Treat ALK-Positive Locally Advanced or Metastatic NSCLC ByDipanshu DixitDecember 18, 20240Comments
THOUGHTSPOT How Natural Extracts Are Revolutionizing Wellness PracticesByAndrea LaceyDecember 17, 20240Comments
News The US FDA Grants Approval to Celltrion’s Steqeyma (Biosimilar, Stelara) ByDipanshu DixitDecember 17, 20240Comments
VIEWPOINTS ViiV at IDWeek 2024: Dr. Harmony Garges in an Illuminating Dialogue Exchange with PharmaShotsBySaurabh ChaubeyDecember 16, 20240Comments
News Celltrion Secures the CHMP’s Positive Opinion for Eydenzelt (Biosimilar, Eylea), Stoboclo & Osenvelt (Biosimilars, Prolia & Xgeva) and Avtozma (Biosimilar, RoActemra) ByDipanshu DixitDecember 16, 20240Comments
